Integrating Phosphatidylethanol to Enhance Alcohol Quantification in Steatotic Liver Disease and Clinical Trials
Open Access
- 22 December 2025
- journal article
- review article
- Published by Wiley in Liver International
- Vol. 46 (1) , e70489
Abstract
Accurate quantification of alcohol intake is essential for the diagnosis, subclassification, and management of steatotic liver disease (SLD). In everyday clinical practice, alcohol histories rely primarily on physician‐assisted self‐report, with validated questionnaires used variably. Both provider‐level inconsistencies in documentation and patient‐level factors (e.g., recall and social‐desirability biases) can contribute to misclassification of SLD subtypes. Phosphatidylethanol (PEth), a direct alcohol biomarker detectable for ~2–4 weeks, has emerged as a promising objective tool that can complement self‐report. Across diverse SLD populations, PEth consistently uncovers underreported alcohol use, sharpens subclassification, informs prognosis, and enables longitudinal monitoring to guide care. In liver transplantation, PEth supports documentation of abstinence and detection of relapse to enable timely intervention. This mini‐review synthesises current evidence on PEth in SLD, emphasises its value in both clinical and research settings, and outlines priorities for integrating PEth into structured care pathways and clinical trial design to improve outcomes and harmonise endpoints.Keywords
Funding Information
- National Institute on Alcohol Abuse and Alcoholism (K23AA031310)
- American Association for the Study of Liver Diseases
This publication has 31 references indexed in Scilit:
- The stigma of alcohol-related liver disease and its impact on healthcareJournal of Hepatology, 2022
- Factors associated with phosphatidylethanol (PEth) sensitivity for detecting unhealthy alcohol use: An individual patient data meta‐analysisAlcohol, Clinical and Experimental Research, 2021
- Phosphatidylethanol for Monitoring Alcohol Use in Liver Transplant Candidates: An Observational StudyJournal of Clinical Medicine, 2020
- Stability of Phosphatidylethanol 16:0/18:1 in Freshly Drawn, Authentic Samples from Healthy VolunteersJournal of Analytical Toxicology, 2020
- Pilot investigation of a phosphatidylethanol-based contingency management intervention targeting alcohol use.Psychology of Addictive Behaviors, 2017
- Phosphatidylethanol Detects Moderate‐to‐Heavy Alcohol Use in Liver Transplant RecipientsAlcohol, Clinical and Experimental Research, 2017
- Low to moderate lifetime alcohol consumption is associated with less advanced stages of fibrosis in non-alcoholic fatty liver diseaseScandinavian Journal of Gastroenterology, 2016
- Validation of Blood Phosphatidylethanol as an Alcohol Consumption Biomarker in Patients with Chronic Liver DiseaseAlcohol, Clinical and Experimental Research, 2014
- Social desirability biases in self-reported alcohol consumption and harmsAddictive Behaviors, 2010
- Recall Bias for Seven-Day Recall Measurement of Alcohol Consumption Among Emergency Department Patients: Implications for Case-Crossover Designs*Journal of Studies on Alcohol and Drugs, 2007